Literature DB >> 27379735

Low-Level Laser Irradiation Improves Depression-Like Behaviors in Mice.

Zhiqiang Xu1,2, Xiaobo Guo2, Yong Yang3, Donovan Tucker4, Yujiao Lu4, Ning Xin1, Gaocai Zhang1,2, Lingli Yang1, Jizhen Li5, Xiangdong Du3, Quanguang Zhang6, Xingshun Xu7,8.   

Abstract

Major depressive disorder (MDD) is one of the leading forms of psychiatric disorders, characterized by aversion to mobility, neurotransmitter deficiency, and energy metabolic decline. Low-level laser therapy (LLLT) has been investigated in a variety of neurodegenerative disorders associated with mitochondrial dysfunction and functional impairments. The goal of this study was to examine the effect of LLLT on depression-like behaviors and to explore the potential mechanism by detecting mitochondrial function following LLLT. Depression models in space restriction mice and Abelson helper integration site-1 (Ahi1) knockout (KO) mice were employed in this work. Our results revealed that LLLT effectively improved depression-like behaviors, in the two depression mice models, by decreasing immobility duration in behavioral despair tests. In addition, ATP biosynthesis and the level of mitochondrial complex IV expression and activity were significantly elevated in prefrontal cortex (PFC) following LLLT. Intriguingly, LLLT has no effects on ATP content and mitochondrial complex I-IV levels in other tested brain regions, hippocampus and hypothalamus. As a whole, these findings shed light on a novel strategy of transcranial LLLT on depression improvement by ameliorating neurotransmitter abnormalities and promoting mitochondrial function in PFC. The present work provides concrete groundwork for further investigation of LLLT for depression treatment.

Entities:  

Keywords:  Depression; Low-level laser therapy; Mitochondria; Neurotransmitter deficiency

Mesh:

Substances:

Year:  2016        PMID: 27379735      PMCID: PMC5215986          DOI: 10.1007/s12035-016-9983-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  51 in total

Review 1.  The role of dopamine in the pathophysiology of depression.

Authors:  Boadie W Dunlop; Charles B Nemeroff
Journal:  Arch Gen Psychiatry       Date:  2007-03

Review 2.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

Review 3.  Mitochondria and degenerative disorders.

Authors:  M Orth; A H Schapira
Journal:  Am J Med Genet       Date:  2001

4.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness.

Authors:  H S Mayberg; M Liotti; S K Brannan; S McGinnis; R K Mahurin; P A Jerabek; J A Silva; J L Tekell; C C Martin; J L Lancaster; P T Fox
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

5.  Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy.

Authors:  Julio C Rojas; Jung Lee; Joseph M John; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

6.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

7.  Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression.

Authors:  Gislaine T Rezin; Mariane R Cardoso; Cinara L Gonçalves; Giselli Scaini; Daiane B Fraga; Rafael E Riegel; Clarissa M Comim; João Quevedo; Emilio L Streck
Journal:  Neurochem Int       Date:  2008-09-27       Impact factor: 3.921

8.  Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression.

Authors:  T A Klempan; A Sequeira; L Canetti; A Lalovic; C Ernst; J ffrench-Mullen; G Turecki
Journal:  Mol Psychiatry       Date:  2007-10-16       Impact factor: 15.992

Review 9.  Mitochondrial Dysfunction in Depression.

Authors:  Yashika Bansal; Anurag Kuhad
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 10.  Impaired Functional Connectivity in the Prefrontal Cortex: A Mechanism for Chronic Stress-Induced Neuropsychiatric Disorders.

Authors:  Ignacio Negrón-Oyarzo; Francisco Aboitiz; Pablo Fuentealba
Journal:  Neural Plast       Date:  2016-01-19       Impact factor: 3.599

View more
  17 in total

1.  Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions.

Authors:  Ruimin Wang; Yan Dong; Yujiao Lu; Wenli Zhang; Darrell W Brann; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2018-06-27       Impact factor: 5.590

2.  Low-level laser therapy for beta amyloid toxicity in rat hippocampus.

Authors:  Yujiao Lu; Ruimin Wang; Yan Dong; Donovan Tucker; Ningjun Zhao; Md Ejaz Ahmed; Ling Zhu; Timon Cheng-Yi Liu; Robert M Cohen; Quanguang Zhang
Journal:  Neurobiol Aging       Date:  2016-10-11       Impact factor: 4.673

3.  Effects of Chronic Photobiomodulation with Transcranial Near-Infrared Laser on Brain Metabolomics of Young and Aged Rats.

Authors:  Fabrízio Dos Santos Cardoso; Júlio César Claudino Dos Santos; Francisco Gonzalez-Lima; Bruno Henrique Silva Araújo; Rodrigo Álvaro Brandão Lopes-Martins; Sérgio Gomes da Silva
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

4.  Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway.

Authors:  Laís M S Neves; Elaine C D Gonçalves; Juliana Cavalli; Graziela Vieira; Larissa R Laurindo; Róli R Simões; Igor S Coelho; Adair R S Santos; Alexandre M Marcolino; Maíra Cola; Rafael C Dutra
Journal:  Mol Neurobiol       Date:  2017-10-04       Impact factor: 5.590

Review 5.  Brain Photobiomodulation Therapy: a Narrative Review.

Authors:  Farzad Salehpour; Javad Mahmoudi; Farzin Kamari; Saeed Sadigh-Eteghad; Seyed Hossein Rasta; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

6.  Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia-ischemia.

Authors:  Luodan Yang; Yan Dong; Chongyun Wu; Yong Li; Yichen Guo; Baocheng Yang; Xuemei Zong; Michael R Hamblin; Timon C-Y Liu; Quanguang Zhang
Journal:  J Biophotonics       Date:  2019-02-14       Impact factor: 3.207

7.  Expression of AHI1 Rescues Amyloidogenic Pathology in Alzheimer's Disease Model Cells.

Authors:  Lai-Lei Ting; Hsien-Tsung Lu; Shu-Fen Yen; Thi Huong Ngo; Fang-Yu Tu; I-Shih Tsai; Yi-Hua Tsai; Fu-Yen Chang; Xiao-Jiang Li; Shihua Li; Ching-Kuo Lee; Shu-Huei Kao; Yu-Min Kuo; Yung-Feng Lin
Journal:  Mol Neurobiol       Date:  2019-05-07       Impact factor: 5.590

8.  Photobiomodulation Therapy Attenuates Hypoxic-Ischemic Injury in a Neonatal Rat Model.

Authors:  Lorelei Donovan Tucker; Yujiao Lu; Yan Dong; Luodan Yang; Yong Li; Ningjun Zhao; Quanguang Zhang
Journal:  J Mol Neurosci       Date:  2018-07-22       Impact factor: 3.444

9.  Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis.

Authors:  Farzad Salehpour; Fereshteh Farajdokht; Paolo Cassano; Saeed Sadigh-Eteghad; Marjan Erfani; Michael R Hamblin; Maryam Moghadam Salimi; Pouran Karimi; Seyed Hossein Rasta; Javad Mahmoudi
Journal:  Brain Res Bull       Date:  2018-10-29       Impact factor: 4.077

Review 10.  Mechanistic aspects of photobiomodulation therapy in the nervous system.

Authors:  Fatemeh Ramezani; Ali Neshasteh-Riz; Alireza Ghadaksaz; Seyedalireza Moghadas Fazeli; Atousa Janzadeh; Michael R Hamblin
Journal:  Lasers Med Sci       Date:  2021-02-24       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.